The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Open accessAbstract
Biomarkers are measurable indicators of a biological state. As our understanding of diseases meliorates, it is generally accepted that early diagnosis renders the best chance to cure a disease. In the context of proteomics, the discovery phase of identifying bonafide biomarkers and the ensuing validation phase involving large cohort of patient samples are impeded by the complexity of bodily fluid samples. High abundant proteins found in blood plasma make it difficult for the detection of low abundant proteins that may be potential biomarkers. Extracellular vesicles (EVs) have reignited interest in the field of biomarker discovery. EVs contain a tissue‐type signature wherein a rich cargo of proteins and RNA are selectively packaged. In addition, as EVs are membranous structures, the luminal contents are protected from degradation by extracellular proteases and are highly stable in storage conditions. Interestingly, an appealing feature of EV‐based biomarker analysis is the significant reduction in the sample complexity compared to whole bodily fluids. With these prescribed attributes, which are the rate‐limiting factors of traditional biomarker analysis, there is immense potential for the use of EVs for biomarker detection in clinical settings. This review will discuss the current issues with biomarker analysis and the potential use of EVs as reservoirs of disease biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931
Exosomes: Extracellular organelles important in intercellular communication
Mathivanan, S., Ji, H., & Simpson, R. J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.06.006 · Cited by 2,537
Self-citationLötvall, J., Hill, A. F., Hochberg, F., Buzás, E. I., Di Vizio, D., Gardiner, C., Gho, Y. S., Kurochkin, I. V., Mathivanan, S., Quesenberry, P., et al. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.26913 · Cited by 2,451
Self-citationZitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Strimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867 · cited 1×
“Biomarkers are tissues and/or bodily fluid-based measurable indicators of a biological condition [1, 2].”
BackgroundShedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Théry, C., Boussac, M., Véron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., & Amigorena, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7309 · Cited by 1,563
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367
Self-citationDelivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M. N., Lutgens, E., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000610 · Cited by 1,334
Pan, B. T., Teng, K., Wu, C., Adam, M., & Johnstone, R. M. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.942 · Cited by 1,241
Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., & Geuze, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20121 · Cited by 1,228
Tauro, B. J., Greening, D. W., Mathias, R. A., Ji, H., Mathivanan, S., Scott, A. M., & Simpson, R. J. (2012) · Methods · doi:10.1016/j.ymeth.2012.01.002 · Cited by 1,176
Self-citationExosomes: proteomic insights and diagnostic potential
Simpson, R. J., Lim, J. W., Moritz, R. L., & Mathivanan, S. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.17 · Cited by 1,108
Self-citationExoCarta 2012: database of exosomal proteins, RNA and lipids
Mathivanan, S., Fahner, C. J., Reid, G. E., & Simpson, R. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr828 · Cited by 1,094
Self-citationCells release prions in association with exosomes
Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H., & Raposo, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308413101 · Cited by 997
Sawyers, C. L. (2008) · Nature · doi:10.1038/nature06913 · Cited by 983
Biomarkers: Potential uses and limitations
Mayeux, R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.182 · Cited by 916
Exosomes in tumor microenvironment influence cancer progression and metastasis
Kahlert, C., & Kalluri, R. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1020-6 · Cited by 872
Sokolova, V., Ludwig, A.-K., Hornung, S., Rotan, O., Horn, P. A., Epple, M., & Giebel, B. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.05.013 · Cited by 851
Signal-Dependent Membrane Protein Trafficking in the Endocytic Pathway
Trowbridge, I. S., Collawn, J. F., & Hopkins, C. R. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001021 · Cited by 804
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
Nilsson, J., Skog, J., Nordstrand, A., Baranov, V, Mincheva-Nilsson, L., Breakefield, X. O., & Widmark, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605058 · Cited by 776
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
Janowska‐Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez‐Curtis, L., Machalinski, B., Ratajczak, J., & Ratajczak, M. Z. (2005) · International Journal of Cancer · doi:10.1002/ijc.20657 · Cited by 768
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D. D., Carter, B. S., Hochberg, F. H., Breakefield, X. O., Weissleder, R., & Lee, H. (2012) · Nature Medicine · doi:10.1038/nm.2994 · Cited by 759
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 748
Kalra, H., Adda, C. G., Liem, M., Ang, C., Mechler, A., Simpson, R. J., Hulett, M. D., & Mathivanan, S. (2013) · PROTEOMICS · doi:10.1002/pmic.201300282 · Cited by 622
Self-citationMathivanan, S., Lim, J. W. E., Tauro, B. J., Ji, H., Moritz, R. L., & Simpson, R. J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900152-mcp200 · Cited by 591
Self-citationAlvarez, M. L., Khosroheidari, M., Kanchi Ravi, R., & DiStefano, J. K. (2012) · Kidney International · doi:10.1038/ki.2012.256 · Cited by 577
Tumour-released exosomes and their implications in cancer immunity
Iero, M., Valenti, R., Huber, V, Filipazzi, P., Parmiani, G., Fais, S., & Rivoltini, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402237 · Cited by 485
Hristov, M., Erl, W., Linder, S., & Weber, P. C. (2004) · Blood · doi:10.1182/blood-2003-10-3614 · Cited by 484
Follicular Dendritic Cells Carry MHC Class II-Expressing Microvesicles at Their Surface
Denzer, K., van Eijk, M., Kleijmeer, M. J., Jakobson, E., de Groot, C., & J. Geuze, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1259 · Cited by 451
Proteomic and immunologic analyses of brain tumor exosomes
Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., Mitchell, D. A., & Bigner, D. D. (2009) · The FASEB Journal · doi:10.1096/fj.08-122184 · Cited by 429
Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?
Bellingham, S. A., Guo, B. B., Coleman, B. M., & Hill, A. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00124 · Cited by 412
Exosomes: The Future of Biomarkers in Medicine
Properzi, F., Logozzi, M., & Fais, S. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.63 · Cited by 391
Björhall, K., Miliotis, T., & Davidsson, P. (2005) · PROTEOMICS · doi:10.1002/pmic.200400900 · Cited by 384
ExoCarta as a resource for exosomal research
Simpson, R. J., Kalra, H., & Mathivanan, S. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18374 · Cited by 383
Self-citationCirculating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease
Boulanger, C. M., Amabile, N., & Tedgui, A. (2006) · Hypertension · doi:10.1161/01.hyp.0000231507.00962.b5 · Cited by 372
Adhesion and signaling by B cell‐derived exosomes: the role of integrins
Clayton, A., Turkes, A., Dewitt, S., Steadman, R., Mason, M. D., & Hallett, M. B. (2004) · The FASEB Journal · doi:10.1096/fj.03-1094fje · Cited by 339
Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway
Nguyen, D. G., Booth, A., Gould, S. J., & Hildreth, J. E. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309009200 · Cited by 336
"Tolerosomes" are produced by intestinal epithelial cells
Karlsson, M., Lundin, S., Dahlgren, U., Kahu, H., Pettersson, I., & Telemo, E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2892::aid-immu2892>3.0.co;2-i · Cited by 304
Gangoda, L., Boukouris, S., Liem, M., Kalra, H., & Mathivanan, S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400234 · Cited by 301
Self-citationCossetti, C., Iraci, N., Mercer, T. R., Leonardi, T., Alpi, E., Drago, D., Alfaro-Cervello, C., Saini, H. K., Davis, M. P., Schaeffer, J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.020 · Cited by 299
Self-citationProteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC
Li, Y., Zhang, Y., Qiu, F., & Qiu, Z. (2011) · ELECTROPHORESIS · doi:10.1002/elps.201000598 · Cited by 290
Analysis of exosome release and its prognostic value in human colorectal cancer
Silva, J., Garcia, V., Rodriguez, M., Compte, M., Cisneros, E., Veguillas, P., Garcia, J. M., Dominguez, G., Campos‐Martin, Y., Cuevas, J., et al. (2012) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.21926 · Cited by 287
Exosomes as Biomarker Treasure Chests for Prostate Cancer
Duijvesz, D., Luider, T., Bangma, C. H., & Jenster, G. (2011) · European Urology · doi:10.1016/j.eururo.2010.12.031 · Cited by 278
Smith, T. J., Davidson, N. E., Schapira, D. V., Grunfeld, E., Muss, H. B., Vogel, V. G., & Somerfield, M. R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1080 · Cited by 252
Good, D. M., Thongboonkerd, V., Novak, J., Bascands, J.-L., Schanstra, J. P., Coon, J. J., Dominiczak, A., & Mischak, H. (2007) · Journal of Proteome Research · doi:10.1021/pr070529w · Cited by 244
Molecular epidemiology: recent advances and future directions
Perera, F. P., & Weinstein, I. B. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.517 · Cited by 242
Tumor Vesicle—Associated CD147 Modulates the Angiogenic Capability of Endothelial Cells
Millimaggi, D., Mari, M., D'Ascenzo, S., Carosa, E., Jannini, E. A., Zucker, S., Carta, G., Pavan, A., & Dolo, V. (2007) · Neoplasia · doi:10.1593/neo.07133 · Cited by 237
The role of exosomes in the processing of proteins associated with neurodegenerative diseases
Vella, L. J., Sharples, R. A., Nisbet, R. M., Cappai, R., & Hill, A. F. (2008) · European Biophysics Journal · doi:10.1007/s00249-007-0246-z · Cited by 235
Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
Hong, C.-S., Muller, L., Whiteside, T. L., & Boyiadzis, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00160 · Cited by 228
Hori, S. S., & Gambhir, S. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003110 · Cited by 227
Amzallag, N., Passer, B. J., Allanic, D., Segura, E., Théry, C., Goud, B., Amson, R., & Telerman, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404850200 · Cited by 222
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
Duijvesz, D., Burnum-Johnson, K. E., Gritsenko, M. A., Hoogland, A. M., Vredenbregt-van den Berg, M. S., Willemsen, R., Luider, T., Paša-Tolić, L., & Jenster, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082589 · Cited by 208
An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum
Ahmed, N., Barker, G., Oliva, K., Garfin, D., Talmadge, K., Georgiou, H., Quinn, M., & Rice, G. (2003) · PROTEOMICS · doi:10.1002/pmic.200300465 · Cited by 197
Biological markers in epidemiology
Hulka, B. S., Wilcosky, T. C., & Griffith, J. D. (1990) · Oxford University Press eBooks · Cited by 171
Mutant proteins as cancer-specific biomarkers
Wang, Q., Chaerkady, R., Wu, J., Hwang, H. J., Papadopoulos, N., Kopelovich, L., Maitra, A., Matthaei, H., Eshleman, J. R., Hruban, R. H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019203108 · Cited by 168
Dear, J. W., Street, J. M., & Bailey, M. A. (2013) · PROTEOMICS · doi:10.1002/pmic.201200285 · Cited by 163
How Shall We Use the Proteomics Toolbox for Biomarker Discovery?
Lescuyer, P., Hochstrasser, D., & Rabilloud, T. (2007) · Journal of Proteome Research · doi:10.1021/pr0702060 · Cited by 161
Diagnostic and therapeutic potentials of exosomes in CNS diseases
Kawiková, I., & Askenase, P. W. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.070 · Cited by 148
Cellular prion protein is released on exosomes from activated platelets
Robertson, C., Booth, S. A., Beniac, D. R., Coulthart, M. B., Booth, T. F., & McNicol, A. (2006) · Blood · doi:10.1182/blood-2005-02-0802 · Cited by 137
Candidate biomarkers in exosome‐like vesicles purified from rat and mouse urine samples
Conde‐Vancells, J., Rodríguez‐Suárez, E., González, E., Berisa, A., Gil‐Carton, D., Embade, N., Valle, M., Luka, Z., Elortza, F., Wagner, C., et al. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900103 · Cited by 132
Translational genomics: The challenge of developing cancer biomarkersPreprint
Brooks, J. D. (2012) · Genome Research · doi:10.1101/gr.124347.111 · Cited by 123
CD2AP mRNA in urinary exosome as biomarker of kidney disease
Lv, L., Cao, Y., Pan, M., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.10.003 · Cited by 121
Effect of Immunoaffinity Depletion of Human Serum during Proteomic Investigations
Yocum, A. K., Yu, K. H., Oe, T., & Blair, I. A. (2005) · Journal of Proteome Research · doi:10.1021/pr0501721 · Cited by 120
Body fluid proteomics: Prospects for biomarker discovery
Ahn, S., & Simpson, R. J. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700217 · Cited by 118
Cocucci, E., Racchetti, G., Podini, P., & Meldolesi, J. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00566.x · Cited by 108
Use and Isolation of Urinary Exosomes as Biomarkers for Diabetic Nephropathy
Musante, L., Tataruch, D., & Holthöfer, H. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00149 · Cited by 107
Comparison of protein enrichment strategies for proteome analysis of plasma
Bandow, J. E. (2010) · PROTEOMICS · doi:10.1002/pmic.200900431 · Cited by 105
Grammatikakis, N., Vultur, A., Ramana, C. V., Siganou, A., Schweinfest, C. W., Watson, D. K., & Raptis, L. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109200200 · Cited by 97
Simpson, R. J., & Mathivanan, S. (2012) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.10000e10 · Cited by 90
Self-citationPhenotypic and functional characterization of intestinal epithelial exosomes
Mallegol, J., van Niel, G., & Heyman, M. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.04.001 · Cited by 87
The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma.
Nazlı, O., Bozdağ, A. D., Tansuğ, T., Kir, R., & Kaymak, E. (2000) · PubMed · Cited by 72
Enrichment and localization of ganglioside GD3 and caveolin-1 in shed tumor cell membrane vesicles
Dolo, V., Li, R., Dillinger, M., Flati, S., Manela, J., Taylor, B. J., Pavan, A., & Ladisch, S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00063-9 · Cited by 71
Kobayashi, T., Okamoto, H., Yamada, J.-I., et al. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90464-4 · Cited by 32
Cited by
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.009 · Cited by 2,003
ExoCarta: A Web-Based Compendium of Exosomal Cargo
Keerthikumar, S., Chisanga, D., Ariyaratne, D., Al Saffar, H., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.019 · Cited by 1,452
Self-citationIsolation of Extracellular Vesicles: General Methodologies and Latest Trends
Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V., & Laktionov, P. P. (2018) · BioMed Research International · doi:10.1155/2018/8545347 · Cited by 1,243
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Gámez-Valero, A., Monguió-Tortajada, M., Carreras-Planella, L., Franquesa, M., Beyer, K., & Borràs, F. E. (2016) · Scientific Reports · doi:10.1038/srep33641 · Cited by 594
Metadata
- Authors
- Boukouris, S., & Mathivanan, S.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2015-03-19
- Volume
- 9
- Issue
- 3-4
- Pages
- 358-367
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2171000684
- Cited by
- 586
- References
- 84
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.